Memo To File: How US FDA Decided Which Janssen Vaccine Drug Substance Batches Were OK To Use

 
• By Bowman Cox
  
Janssen COVID vaccine
fda bares thinking on vaccine drug substance cross-contamination issue
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from Compliance